GSK106 (hydrochloride) |
カタログ番号GC43787 |
GSK106 (塩酸塩) は、選択的 PAD4 阻害剤である GSK484 および GSK199 の不活性コントロールです。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1652591-82-6
Sample solution is provided at 25 µL, 10mM.
Protein arginine deiminase 4 (PAD4) mediates the transformation of protein arginine into citrulline. Citrullination of proteins has normal roles in gene regulation and pathological roles in immunological and inflammatory diseases. GSK106 is an inactive control for the selective PAD4 inhibitors, GSK484 and GSK199 . It does not inhibit PAD4 nor does it prevent the citrullination of PAD4 target proteins or the formation of neutrophil extracellular traps in mouse or human neutrophils (IC50s > 100 µM). See the Structural Genomics Consortium (SGC) website for more information on both GSK484 and GSK106.
Average Rating: 5
(Based on Reviews and 11 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *